Skip to main content
. 2020 Dec 15;8(1):e912. doi: 10.1212/NXI.0000000000000912

Table 5.

OR with 95% CI of developing MS for subjects with different combinations of DRB1*15:01 status, BMI at age 20 years, and anti-EBNA-1 antibody levels

graphic file with name NEURIMMINFL2020029900t5.jpg